Said Darwazah, Chairman and CEO of Hikma, awarded Global Generics “Leader of the Year”

London, 12 October 2016 – Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody’s / BB+ S&P, both stable), the fast growing multinational pharmaceutical group, announce that Said Darwazah, Chairman and Chief Executive Officer of the Group has received the “Leader of the Year Award” at the Third Global Generics and Biosimilars Awards held in Barcelona on 4 October 2016. The award was given in recognition of Said Darwazah’s distinguished leadership and vision.

Press Release Corporate 12 October 2016

Said Darwazah, Chairman and Chief Executive Officer of Hikma, said: “I am delighted and honoured to receive this award. The combined contributions of all of Hikma’s employees across our global markets have helped to drive strong growth and performance and, most importantly, to continue delivering high-quality affordable generic and branded generic medicines to patients in need.”

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.